Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care

NCT01410383 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Heterozygous Familial Hypercholesterolaemia

Interventions

DRUG: Placebo
DRUG: Eprotirome
DRUG: Eprotirome

Sponsor

Karo Bio AB